questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Composés benzhydryliques
Orphénadrine
Orphénadrine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Language Development Disorders
Diagnostic
5
Douleur musculaire
Évaluation clinique
Imagerie médicale
Analyses sanguines
Spasmes musculaires
Indications thérapeutiques
Raideur musculaire
Symptômes cliniques
Fibromyalgie
Traitement de la douleur
Symptômes
5
Effets secondaires
Somnolence
Réactions allergiques
Éruptions cutanées
Troubles de la vision
Effets indésirables
Palpitations
Difficultés respiratoires
Prévention
5
Prévention des douleurs
Exercices physiques
Alimentation équilibrée
Santé musculaire
Stress
Tensions musculaires
Étirements
Flexibilité musculaire
Repos
Récupération musculaire
Traitements
5
Administration orale
Comprimés
Posologie
Traitement médicamenteux
Interactions médicamenteuses
Consultation médicale
Avantages thérapeutiques
Soulagement de la douleur
Douleurs chroniques
Efficacité thérapeutique
Complications
5
Complications
Troubles cardiaques
Dépendance
Utilisation prolongée
Complications graves
Convulsions
Gestion des complications
Ajustement du traitement
Fonction hépatique
Tests de laboratoire
Facteurs de risque
5
Facteurs de risque
Âge avancé
Personnes âgées
Sensibilité aux médicaments
Alcool
Efficacité médicamenteuse
Antécédents médicaux
Maladies cardiaques
Femmes enceintes
Précautions médicamenteuses
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Orphénadrine : Questions médicales les plus fréquentes",
"headline": "Orphénadrine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Orphénadrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-18",
"dateModified": "2025-03-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Orphénadrine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés benzhydryliques",
"url": "https://questionsmedicales.fr/mesh/D001559",
"about": {
"@type": "MedicalCondition",
"name": "Composés benzhydryliques",
"code": {
"@type": "MedicalCode",
"code": "D001559",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Orphénadrine",
"alternateName": "Orphenadrine",
"code": {
"@type": "MedicalCode",
"code": "D009966",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "L S Sorokina",
"url": "https://questionsmedicales.fr/author/L%20S%20Sorokina",
"affiliation": {
"@type": "Organization",
"name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "D V Ryabova",
"url": "https://questionsmedicales.fr/author/D%20V%20Ryabova",
"affiliation": {
"@type": "Organization",
"name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "A A Eremenko",
"url": "https://questionsmedicales.fr/author/A%20A%20Eremenko",
"affiliation": {
"@type": "Organization",
"name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Shereen A Boltia",
"url": "https://questionsmedicales.fr/author/Shereen%20A%20Boltia",
"affiliation": {
"@type": "Organization",
"name": "Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt."
}
},
{
"@type": "Person",
"name": "Aya T Soudi",
"url": "https://questionsmedicales.fr/author/Aya%20T%20Soudi",
"affiliation": {
"@type": "Organization",
"name": "Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "What risk factors for Developmental Language Disorder can tell us about the neurobiological mechanisms of language development.",
"datePublished": "2023-09-21",
"url": "https://questionsmedicales.fr/article/37741516",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neubiorev.2023.105398"
}
},
{
"@type": "ScholarlyArticle",
"name": "Can Retrieval Practice Facilitate Verb Learning in Children With Developmental Language Disorder and Their Peers With Typical Language Development?",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36898133",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2022_JSLHR-22-00509"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disentangling Language Disorder and Bilingualism in Children with Developmental Language Disorder and Autism Spectrum Disorder: Evidence from Writing.",
"datePublished": "2022-09-10",
"url": "https://questionsmedicales.fr/article/36087157",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10803-022-05727-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Language Environment at Home of Children With (a Suspicion of) a Developmental Language Disorder and Relations With Standardized Language Measures.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37418756",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2023_JSLHR-23-00066"
}
},
{
"@type": "ScholarlyArticle",
"name": "Language intervention in bilingual children with developmental language disorder: A systematic review.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36428270",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1460-6984.12803"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzhydryliques",
"item": "https://questionsmedicales.fr/mesh/D001559"
},
{
"@type": "ListItem",
"position": 8,
"name": "Orphénadrine",
"item": "https://questionsmedicales.fr/mesh/D009966"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Orphénadrine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Orphénadrine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Orphénadrine",
"description": "Comment diagnostiquer une douleur musculaire nécessitant l'orphénadrine ?\nQuels tests sont utiles avant de prescrire l'orphénadrine ?\nL'orphénadrine est-elle indiquée pour tous les types de douleurs ?\nQuels signes cliniques justifient l'utilisation de l'orphénadrine ?\nL'orphénadrine est-elle utilisée en cas de fibromyalgie ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Language+Development+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Orphénadrine",
"description": "Quels sont les effets secondaires courants de l'orphénadrine ?\nL'orphénadrine peut-elle provoquer des réactions allergiques ?\nQuels symptômes indiquent une surdose d'orphénadrine ?\nL'orphénadrine peut-elle causer des troubles de la vision ?\nQuels symptômes nécessitent l'arrêt immédiat de l'orphénadrine ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Language+Development+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Orphénadrine",
"description": "Comment prévenir les douleurs nécessitant l'orphénadrine ?\nL'alimentation joue-t-elle un rôle dans la prévention des douleurs musculaires ?\nLe stress peut-il aggraver les douleurs musculaires ?\nDes étirements réguliers peuvent-ils prévenir les douleurs ?\nLe repos est-il important pour prévenir les douleurs musculaires ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Language+Development+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Orphénadrine",
"description": "Comment l'orphénadrine est-elle administrée ?\nQuelle est la posologie standard de l'orphénadrine ?\nL'orphénadrine peut-elle être combinée avec d'autres médicaments ?\nQuels sont les avantages de l'orphénadrine par rapport à d'autres traitements ?\nL'orphénadrine est-elle efficace contre les douleurs chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Language+Development+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Orphénadrine",
"description": "Quelles complications peuvent survenir avec l'orphénadrine ?\nL'orphénadrine peut-elle entraîner une dépendance ?\nQuels signes indiquent une complication grave de l'orphénadrine ?\nComment gérer les complications liées à l'orphénadrine ?\nL'orphénadrine peut-elle affecter la fonction hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Language+Development+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Orphénadrine",
"description": "Quels facteurs augmentent le risque d'effets secondaires de l'orphénadrine ?\nLes personnes âgées sont-elles plus sensibles à l'orphénadrine ?\nL'usage d'alcool influence-t-il l'efficacité de l'orphénadrine ?\nLes antécédents médicaux influencent-ils l'utilisation de l'orphénadrine ?\nLes femmes enceintes peuvent-elles prendre de l'orphénadrine ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Language+Development+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une douleur musculaire nécessitant l'orphénadrine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'historique des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utiles avant de prescrire l'orphénadrine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie et des analyses sanguines peuvent être réalisés pour évaluer l'état musculaire."
}
},
{
"@type": "Question",
"name": "L'orphénadrine est-elle indiquée pour tous les types de douleurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est principalement indiquée pour les douleurs musculaires et les spasmes."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques justifient l'utilisation de l'orphénadrine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs aiguës, des spasmes et une raideur musculaire."
}
},
{
"@type": "Question",
"name": "L'orphénadrine est-elle utilisée en cas de fibromyalgie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être utilisée pour soulager certains symptômes de la fibromyalgie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants de l'orphénadrine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent la sécheresse buccale, la somnolence et des vertiges."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle provoquer des réactions allergiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques comme des éruptions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose d'orphénadrine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent confusion, hallucinations et tachycardie."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle causer des troubles de la vision ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner une vision floue ou des troubles visuels temporaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent l'arrêt immédiat de l'orphénadrine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des palpitations, des éruptions cutanées ou des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les douleurs nécessitant l'orphénadrine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices réguliers, une bonne posture et des pauses fréquentes peuvent aider."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention des douleurs musculaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut contribuer à la santé musculaire."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver les douleurs musculaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les tensions musculaires et les douleurs."
}
},
{
"@type": "Question",
"name": "Des étirements réguliers peuvent-ils prévenir les douleurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les étirements réguliers aident à maintenir la flexibilité et à prévenir les douleurs."
}
},
{
"@type": "Question",
"name": "Le repos est-il important pour prévenir les douleurs musculaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un repos adéquat est essentiel pour la récupération musculaire."
}
},
{
"@type": "Question",
"name": "Comment l'orphénadrine est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement administrée par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de l'orphénadrine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie standard est de 100 mg deux fois par jour, selon les besoins."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle être combinée avec d'autres médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de consulter un médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Quels sont les avantages de l'orphénadrine par rapport à d'autres traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle offre un soulagement rapide des spasmes musculaires et des douleurs."
}
},
{
"@type": "Question",
"name": "L'orphénadrine est-elle efficace contre les douleurs chroniques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être efficace pour certaines douleurs chroniques, mais pas pour toutes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'orphénadrine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des troubles cardiaques ou des problèmes neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle entraîner une dépendance ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle a un faible potentiel de dépendance, mais une utilisation prolongée doit être surveillée."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave de l'orphénadrine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques, des évanouissements ou des convulsions."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à l'orphénadrine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est crucial de consulter un médecin pour ajuster le traitement ou changer de médicament."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle affecter la fonction hépatique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests de la fonction hépatique peuvent être nécessaires en cas d'utilisation prolongée."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets secondaires de l'orphénadrine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies préexistantes et l'utilisation d'autres médicaments augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus sensibles à l'orphénadrine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets secondaires de l'orphénadrine."
}
},
{
"@type": "Question",
"name": "L'usage d'alcool influence-t-il l'efficacité de l'orphénadrine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'alcool peut augmenter les effets sédatifs de l'orphénadrine."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils l'utilisation de l'orphénadrine ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies cardiaques ou neurologiques peuvent limiter son utilisation."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles prendre de l'orphénadrine ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'orphénadrine doit être utilisée avec prudence chez les femmes enceintes, après avis médical."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 15/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Petrovsky Russian Research Center of Surgery, Moscow, Russia.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Petrovsky Russian Research Center of Surgery, Moscow, Russia.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Petrovsky Russian Research Center of Surgery, Moscow, Russia.
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Peoples' Friendship University of Russia, Moscow, Russia.
City Clinical Hospital No. 24, Moscow, Russia.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Peoples' Friendship University of Russia, Moscow, Russia.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Peoples' Friendship University of Russia, Moscow, Russia.
City Clinical Hospital No. 24, Moscow, Russia.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute for Nanotechnology and Water Sustainability, College of Science, Engineering and Technology, University of South Africa, Florida Science Campus, Roodepoort, 1710, South Africa.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria. christian.klampfl@jku.at.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Department of Tropical medicine, Faculty of Medicine, Tanta University.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Department of Tropical medicine, Faculty of Medicine, Tanta University.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Department of Public health, Menofia University, Egypt.
Publications dans "Orphénadrine" :
Language is a complex multidimensional cognitive system that is connected to many neurocognitive capacities. The development of language is therefore strongly intertwined with the development of these...
Children with developmental language disorder (DLD) have well-documented verb learning difficulties. In this study, we asked whether the inclusion of retrieval practice during the learning period woul...
Eleven children with DLD (...
Recall testing immediately after the learning period and 1 week later revealed greater recall for novel verbs in the RSR condition than for novel verbs in the RS condition. This was true for both grou...
Retrieval practice provides benefits to verb learning-an important finding given the challenges that verbs present to children with DLD. However, these benefits do not appear to automatically translat...
Twenty-eight Albanian-Greek bilingual children with Developmental Language Disorder and 28 children with Autism Spectrum Disorder but no language impairment, along with 28 typically-developing, age-, ...
This study compares the home language environments of children with (a suspicion of) developmental language disorder (DLD) with that of children with typical development (TD). It does so by adopting n...
Ninety-nine 2- to 4-year-old toddlers participated: 59 with (a suspicion of) DLD and 40 with TD. LENA metrics on adult word count, conversational turn count, and child vocalization count were obtained...
We found lower adult word count, conversational turn count, and child vocalization count in the DLD group, independent of multilingualism but not of parental education. In the DLD group, receptive voc...
Toddlers with (a suspicion of) DLD vocalize less at home than children with TD. They also hear fewer adult words and experience fewer conversational turns. Children with DLD's language outcomes are to...
Although there is a growing body of literature on cognitive and language processing in bilingual children with developmental language disorder (DLD), there is a major gap in the evidence for language ...
To examine evidence for language intervention and cross-language transfer effects in bilingual children with DLD. Specifically, the study aimed to review intervention evidence targeting non-linguistic...
We carried out searches in five electronic databases: CINAHL, Scopus, Psychinfo, Proquest and Sciencedirect. Data from selected papers were extracted and organized into the three following categories:...
We included 14 papers in the review. The majority indicated evidence for vocabulary intervention. There was limited evidence for intervention targeting phonology or morphosyntax. Cross-language genera...
The present review indicates that there is a significant gap in the literature regarding language intervention for several key language areas such as morphosyntax, narrative skills and literacy. There...
What is already known on the subject Previous studies have examined the effects of bi- and monolingual intervention in bilingual children with DLD. Although the results indicated superior effects for ...
Speech-language pathologists (SLPs) have multiple roles and responsibilities related to language and literacy instruction in schools. The purpose of this exploratory, qualitative study was to analyze ...
Eight school-based SLPs participated in a 1-hr virtual focus group conducted via Zoom recording technology. The researchers used a conventional content analysis approach to analyze the focus group dat...
The researchers developed two themes: (a) SLPs identified repeated exposure to books, peer interaction, and teaching vocabulary with visual supports and props as key elements of language and literacy ...
SLPs identified several instructional practices inclusive pre-K teachers could be taught to use during professional development programs to support the emergent literacy development of children with D...
Systematic reviews of bilingual children's reading development are very limited, and none of which solely focus on predictors of reading difficulties among those with developmental language disorder (...
The search parameters used in this scoping review included peer-reviewed journal articles written in English from 2000 to 2022 in order to synthesize the most recent empirical work, a focus on early c...
The present review yielded nine articles, which all examined the predictive validity of either a measure or task with the ultimate goal of improving early identification of reading difficulties. Signi...
To conclude, this review demonstrates that this is a highly under-researched topic. To have ended up including only nine articles that fit the criteria of our search reveals a large gap in the researc...
Developmental language disorder (DLD) is a relatively new, internationally promoted term to describe individuals with language impairments not secondary to a biomedical condition. This study aimed to ...
After completing an online presurvey to evaluate current comfort levels in using DLD terminology and current knowledge of DLD, currently practicing SLPs viewed a 45-min prerecorded educational video o...
After filtering to remove likely fraudulent responders, we included 77 participants in all analyses. Presurvey Likert scale responses indicated at least some comfort in using DLD terminology. Addition...
Despite some limitations, it was concluded that diffusion efforts, such as educational presentations, are likely to increase SLPs' comfort levels in using DLD terminology and SLPs' knowledge of DLD....
https://doi.org/10.23641/asha.22344349....
Children with developmental language disorder (DLD) regularly use the bare form of verbs (e.g., dance) instead of inflected forms (e.g., danced). We propose an account of this behavior in which proces...
Individuals with developmental language disorder or Williams syndrome are reported to use more gestures than individuals with typical development. However, these two groups differ considerably in visu...
We first examined whether children with both developmental language disorder and children Williams syndrome do indeed use more gestures. Our second aim was to disentangle the role of vocabulary and vi...
In a cross-sectional group design, three participant groups watched and then retold a cartoon: children with typical development (n = 25), children with developmental language disorder (n = 25) and ch...
Between-group comparisons showed that individuals with developmental language disorder or Williams syndrome did indeed use more gestures. Poisson loglinear modelling demonstrated that a relative highe...
Regardless of neurodevelopmental condition or typical development, a higher use of supplementary gestures was influenced by expressive vocabulary skills. Children with lower vocabulary skills spontane...
What is already known on the subject Children with developmental language disorder and children with Williams syndrome are more inclined to use gestures than typically developing children. Research co...